Systemic and uterine responsiveness to angiotensin II and norepinephrine in estrogen-treated nonpregnant sheep

Raymond P. Naden, Charles R. Rosenfeld

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Pregnancy is associated with uterine and systemic vasodilation and reduced vascular reactivity to angiotensin II and perhaps norepinephrine. The uteroplacental vasculature is relatively refractory to angiotensin II but very sensitive to norepinephrine. To investigate the possible role of the high levels of estrogen in pregnancy mediating these hemodynamic changes, we examined systemic and uterine vascular responsiveness to angiotensin II and norepinephrine in eight chronically instrumented nonpregnant sheep treated with 17β-estradiol. In these animals, 17β-estradiol produced significant systemic and uterine vasodilation without changing arterial pressure; cardiac output increased from 5.3 ± 0.3 to 6.7 ± 0.4 L/min, and uterine blood flow increased from 26 ± 3 to 218 ± 13 ml/min (mean ± SE). Treatment with 17β-estradiol reduced the increases in systemic vascular resistance produced by angiotensin II and norepinephrine by 25% and 35%, respectively. After 17β-estradiol treatment, the uterine vascular responses were compared to the systemic vascular responses; the uterine responses to angiotensin II were only half the systemic responses, whereas the uterine responses to norepinephrine were six times greater than the systemic responses and were associated with decreases in uterine blood flow of 35% to 40%. These hemodynamic features of nonpregnant sheep treated with estrogen are strikingly similar to previous observations in sheep during pregnancy.

Original languageEnglish (US)
Pages (from-to)417-425
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume153
Issue number4
DOIs
StatePublished - Oct 15 1985

Fingerprint

Angiotensin II
Sheep
Norepinephrine
Estrogens
Blood Vessels
Estradiol
Vasodilation
Pregnancy
Hemodynamics
Cardiac Output
Vascular Resistance
Arterial Pressure

Keywords

  • angiotensin II
  • estrogen-treated nonpregnant sheep
  • norepinephrine
  • Uterine and systemic vascular responses

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

@article{567f66c3345b48ffb5b895bd8974d183,
title = "Systemic and uterine responsiveness to angiotensin II and norepinephrine in estrogen-treated nonpregnant sheep",
abstract = "Pregnancy is associated with uterine and systemic vasodilation and reduced vascular reactivity to angiotensin II and perhaps norepinephrine. The uteroplacental vasculature is relatively refractory to angiotensin II but very sensitive to norepinephrine. To investigate the possible role of the high levels of estrogen in pregnancy mediating these hemodynamic changes, we examined systemic and uterine vascular responsiveness to angiotensin II and norepinephrine in eight chronically instrumented nonpregnant sheep treated with 17β-estradiol. In these animals, 17β-estradiol produced significant systemic and uterine vasodilation without changing arterial pressure; cardiac output increased from 5.3 ± 0.3 to 6.7 ± 0.4 L/min, and uterine blood flow increased from 26 ± 3 to 218 ± 13 ml/min (mean ± SE). Treatment with 17β-estradiol reduced the increases in systemic vascular resistance produced by angiotensin II and norepinephrine by 25{\%} and 35{\%}, respectively. After 17β-estradiol treatment, the uterine vascular responses were compared to the systemic vascular responses; the uterine responses to angiotensin II were only half the systemic responses, whereas the uterine responses to norepinephrine were six times greater than the systemic responses and were associated with decreases in uterine blood flow of 35{\%} to 40{\%}. These hemodynamic features of nonpregnant sheep treated with estrogen are strikingly similar to previous observations in sheep during pregnancy.",
keywords = "angiotensin II, estrogen-treated nonpregnant sheep, norepinephrine, Uterine and systemic vascular responses",
author = "Naden, {Raymond P.} and Rosenfeld, {Charles R.}",
year = "1985",
month = "10",
day = "15",
doi = "10.1016/0002-9378(85)90080-8",
language = "English (US)",
volume = "153",
pages = "417--425",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Systemic and uterine responsiveness to angiotensin II and norepinephrine in estrogen-treated nonpregnant sheep

AU - Naden, Raymond P.

AU - Rosenfeld, Charles R.

PY - 1985/10/15

Y1 - 1985/10/15

N2 - Pregnancy is associated with uterine and systemic vasodilation and reduced vascular reactivity to angiotensin II and perhaps norepinephrine. The uteroplacental vasculature is relatively refractory to angiotensin II but very sensitive to norepinephrine. To investigate the possible role of the high levels of estrogen in pregnancy mediating these hemodynamic changes, we examined systemic and uterine vascular responsiveness to angiotensin II and norepinephrine in eight chronically instrumented nonpregnant sheep treated with 17β-estradiol. In these animals, 17β-estradiol produced significant systemic and uterine vasodilation without changing arterial pressure; cardiac output increased from 5.3 ± 0.3 to 6.7 ± 0.4 L/min, and uterine blood flow increased from 26 ± 3 to 218 ± 13 ml/min (mean ± SE). Treatment with 17β-estradiol reduced the increases in systemic vascular resistance produced by angiotensin II and norepinephrine by 25% and 35%, respectively. After 17β-estradiol treatment, the uterine vascular responses were compared to the systemic vascular responses; the uterine responses to angiotensin II were only half the systemic responses, whereas the uterine responses to norepinephrine were six times greater than the systemic responses and were associated with decreases in uterine blood flow of 35% to 40%. These hemodynamic features of nonpregnant sheep treated with estrogen are strikingly similar to previous observations in sheep during pregnancy.

AB - Pregnancy is associated with uterine and systemic vasodilation and reduced vascular reactivity to angiotensin II and perhaps norepinephrine. The uteroplacental vasculature is relatively refractory to angiotensin II but very sensitive to norepinephrine. To investigate the possible role of the high levels of estrogen in pregnancy mediating these hemodynamic changes, we examined systemic and uterine vascular responsiveness to angiotensin II and norepinephrine in eight chronically instrumented nonpregnant sheep treated with 17β-estradiol. In these animals, 17β-estradiol produced significant systemic and uterine vasodilation without changing arterial pressure; cardiac output increased from 5.3 ± 0.3 to 6.7 ± 0.4 L/min, and uterine blood flow increased from 26 ± 3 to 218 ± 13 ml/min (mean ± SE). Treatment with 17β-estradiol reduced the increases in systemic vascular resistance produced by angiotensin II and norepinephrine by 25% and 35%, respectively. After 17β-estradiol treatment, the uterine vascular responses were compared to the systemic vascular responses; the uterine responses to angiotensin II were only half the systemic responses, whereas the uterine responses to norepinephrine were six times greater than the systemic responses and were associated with decreases in uterine blood flow of 35% to 40%. These hemodynamic features of nonpregnant sheep treated with estrogen are strikingly similar to previous observations in sheep during pregnancy.

KW - angiotensin II

KW - estrogen-treated nonpregnant sheep

KW - norepinephrine

KW - Uterine and systemic vascular responses

UR - http://www.scopus.com/inward/record.url?scp=0022387907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022387907&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(85)90080-8

DO - 10.1016/0002-9378(85)90080-8

M3 - Article

C2 - 4050915

AN - SCOPUS:0022387907

VL - 153

SP - 417

EP - 425

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -